82293-033-31 : NDC 2026 Code

82293-033-31 : Everolimus ( Everolimus )

Additionally :

You can get information about “82293-033-31” NDC code in 82293-033-31 in HTML format

HTML | 82293-033-31 in TXT (Plain Text) format

TXT | 82293-033-31 in PDF (Portable Document Format)

PDF | 82293-033-31 in XML format

XML formats.

NDC Code : 82293-033-31 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "82293-033-31",
    "PackageDescription": "1 POUCH in 1 CARTON (82293-033-31)  / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-033-30) ",
    "NDC11Code": "82293-0033-31",
    "ProductNDC": "82293-033",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Everolimus",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Everolimus",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260330",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA219955",
    "LabelerName": "Novugen Pharma (USA) LLC.",
    "SubstanceName": "EVEROLIMUS",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-31",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260330",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}